2020
DOI: 10.1093/eurpub/ckaa088
|View full text |Cite
|
Sign up to set email alerts
|

EU health law and policy in and after the COVID-19 crisis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
16
0
1

Year Published

2020
2020
2023
2023

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 14 publications
(17 citation statements)
references
References 9 publications
(7 reference statements)
0
16
0
1
Order By: Relevance
“…The COVID-19 pandemic put EU regulatory capacities to the test, precisely in an area where national authority is strongly protected. 33 New EU vaccination policies and the EU4Health 2021‒27 research programme 34 point towards stronger EU regulation, 33 which might also impact health workforce governance. EU4Health aims to ‘establishing a reserve of medical, healthcare & support staff’.…”
Section: Resultsmentioning
confidence: 99%
“…The COVID-19 pandemic put EU regulatory capacities to the test, precisely in an area where national authority is strongly protected. 33 New EU vaccination policies and the EU4Health 2021‒27 research programme 34 point towards stronger EU regulation, 33 which might also impact health workforce governance. EU4Health aims to ‘establishing a reserve of medical, healthcare & support staff’.…”
Section: Resultsmentioning
confidence: 99%
“…Secondly, Decision 1082/2013/EU 96 regulates joint public procurement of medicinal countermeasures in case of outbreaks on large scale or health emergencies. 97 This is a valuable tool in light of the distribution of medicines and vaccines. 98 Thirdly, through the EU Civil Protection Mechanism, which is based on the idea of cooperation, Member States can request assistance in case of disasters.…”
Section: Instruments and Mechanisms Of The Eumentioning
confidence: 99%
“…117 In other words, the EU's action was limited at first, because the Member States had agreed on this while drafting the Treaties. 118 Due to the corona crisis, a tension arose between national interests and principles underlying the EU internal market. 119 Some authors have argued that a rebound to selfishness and prevailing national interests became immediately visible as a consequence.…”
Section: Eu's Slow Startmentioning
confidence: 99%
“…Such a decision gave the European Union the chance to avoid any other disruptive competition on price by a single Member State, preserving the integrity of the Custom Market and fostering the European powers on healthrelated market chapters. The joint procurement procedure was already used in the 2010s during the emergency of H1N1 influenza (Greer & de Ruijter, 2020). Nevertheless, the late approval by the EMA -implementing a brand-new "roll-out" approval mechanism -(European Medicine Agency 2020) together with issues related to export to third countries and difficulties of the suppliers determined a delay in European Vaccine Campaign in early 2021 (Torjesen, 2021;Herszenhorn and Vela 2020).…”
Section: Covid-19: (Limited) Health Coordination In the Eumentioning
confidence: 99%
“…we could not be satisfied with market-related measures. The issues verified with AstraZeneca, the difficulty in early doses supplies due to late rollout and supply to third countries impacted unfairly to the Campaign and, even the initial hurdles seem to be overcome, it is necessary to put in place stronger measures to avoid any disruption in the supply chain that could potentially undermine the scope of the joint procurement (Greer & de Ruijter, 2020).…”
Section: Covid-19: (Limited) Health Coordination In the Eumentioning
confidence: 99%